![Eli Lilly headquarters](https://www.ibj.com/wp-content/uploads/2019/01/lilly-2col-300x200.jpg)
Lilly lands Fast Track designation for potential blockbuster drug
Indianapolis-based Eli Lilly and Co. announced Thursday that it has received a Fast Track designation from the U.S. Food and Drug Administration to investigate its diabetes drug tirzepatide for the treatment of adults with obesity.